Former U.S. President Joe Biden, aged 82, has been diagnosed with stage 4 metastatic prostate cancer, which has spread to his bones. The cancer is characterized by a Gleason score of 9, indicating a highly aggressive form. Despite its severity, the cancer is hormone-sensitive, offering potential for effective treatment
Medical experts have expressed surprise that such an advanced cancer went undetected, especially given Biden’s access to high-quality healthcare. Dr. Marc Siegel and Dr. Howie Forman highlighted the importance of routine screenings like the PSA blood test, which can aid in early detection. Some experts have raised concerns about the possibility of the disease being present during Biden’s presidency, suggesting a potential oversight in regular health evaluations
Treatment options for Biden are being carefully considered. Given the hormone-sensitive nature of his cancer, androgen deprivation therapy (ADT) is a likely course of action. Dr. Christopher Wee, a genitourinary oncologist at the Cleveland Clinic, noted that while stage 4 prostate cancer is not curable, it is treatable. The primary goals are to slow disease progression, maintain quality of life, and extend life expectancy .
Dr. Steven Quay criticized the situation as potential malpractice, emphasizing that prostate cancer typically takes years to metastasize. He questioned how such an advanced stage could have gone unnoticed, considering Biden’s regular medical check-ups
Despite the diagnosis, there is optimism about Biden’s prognosis. Advancements in medical treatments have enabled many patients with similar diagnoses to live for years with a good quality of life. Biden and his family are currently consulting with physicians to determine the most appropriate treatment plan moving forward
The diagnosis has prompted bipartisan support and well-wishes from political figures across the spectrum, including former Presidents Donald Trump and Barack Obama, as well as Vice President Kamala Harris. This outpouring of support underscores the seriousness of the situation and the collective hope for Biden’s recovery.
Biden’s case also brings attention to the broader issue of prostate cancer screening, especially in older men. While routine screening is not commonly recommended for men over 75 due to risks of overdiagnosis and overtreatment, Biden’s diagnosis may prompt a reevaluation of these guidelines. Medical professionals emphasize the importance of informed, shared decision-making regarding prostate cancer screening and the need for proactive health maintenance
As Biden embarks on this personal health journey, the nation watches with concern and hope, reflecting on the importance of early detection and the advancements in cancer treatment that offer patients a chance at extended and meaningful lives.
